{"entity":{"type":"insider","cik":"0001856414","url":"/insider/0001856414","json_url":"/insider/0001856414.json","name":"Marriott Tina","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":27,"first":"2021-11-22","last":"2024-10-28","span_basis":"filed_date"},"name_variants":[{"name":"Marriott Tina","source":"filing","n_filings":9,"first_seen":"2024-02-23","last_seen":"2024-10-28"},{"name":"Larson Tina Marriott","source":"filing","n_filings":18,"first_seen":"2021-11-22","last_seen":"2024-01-29"}],"transactions":[{"id":2092606,"accession":"0001601830-24-000181","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601830-24-000181","line_url":"/filing/0001601830-24-000181#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Marriott Tina","owner_display_name":"Marriott Tina","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":6.3091,"price_display":"6.31","price_state":"stated","total_value":37854.6,"total_display":"37,854.60","total_whole":"37,855","shares_owned_after":521138.0,"shares_owned_after_display":"521,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-24","filed_date":"2024-10-28","scope":"insider"},{"id":2869884,"accession":"0001601830-24-000161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601830-24-000161","line_url":"/filing/0001601830-24-000161#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Marriott Tina","owner_display_name":"Marriott Tina","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":7.0008,"price_display":"7.00","price_state":"stated","total_value":42004.8,"total_display":"42,004.80","total_whole":"42,005","shares_owned_after":521138.0,"shares_owned_after_display":"521,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-26","filed_date":"2024-09-30","scope":"insider"},{"id":2646877,"accession":"0001601830-24-000150","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601830-24-000150","line_url":"/filing/0001601830-24-000150#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Marriott Tina","owner_display_name":"Marriott Tina","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":7.5627,"price_display":"7.56","price_state":"stated","total_value":45376.2,"total_display":"45,376.20","total_whole":"45,376","shares_owned_after":521138.0,"shares_owned_after_display":"521,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-29","filed_date":"2024-09-03","scope":"insider"},{"id":2869877,"accession":"0001601830-24-000105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601830-24-000105","line_url":"/filing/0001601830-24-000105#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Marriott Tina","owner_display_name":"Marriott Tina","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":8.1349,"price_display":"8.13","price_state":"stated","total_value":48809.4,"total_display":"48,809.40","total_whole":"48,809","shares_owned_after":535457.0,"shares_owned_after_display":"535,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-25","filed_date":"2024-07-29","scope":"insider"},{"id":2731780,"accession":"0001601830-24-000095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601830-24-000095","line_url":"/filing/0001601830-24-000095#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Marriott Tina","owner_display_name":"Marriott Tina","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":7.215,"price_display":"7.22","price_state":"stated","total_value":43290.0,"total_display":"43,290.00","total_whole":"43,290","shares_owned_after":535457.0,"shares_owned_after_display":"535,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-27","filed_date":"2024-06-28","scope":"insider"},{"id":2823613,"accession":"0001601830-24-000068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601830-24-000068","line_url":"/filing/0001601830-24-000068#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Marriott Tina","owner_display_name":"Marriott Tina","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":8.775,"price_display":"8.78","price_state":"stated","total_value":26325.0,"total_display":"26,325.00","total_whole":"26,325","shares_owned_after":535457.0,"shares_owned_after_display":"535,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-06-03","scope":"insider"},{"id":2193045,"accession":"0001601830-24-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001601830-24-000045","line_url":"/filing/0001601830-24-000045#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Marriott Tina","owner_display_name":"Marriott Tina","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.6735,"price_display":"7.67","price_state":"stated","total_value":23020.5,"total_display":"23,020.50","total_whole":"23,021","shares_owned_after":543231.0,"shares_owned_after_display":"543,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-25","filed_date":"2024-04-29","scope":"insider"},{"id":2290557,"accession":"0001601830-24-000025","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001601830-24-000025","line_url":"/filing/0001601830-24-000025","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Marriott Tina","owner_display_name":"Marriott Tina","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":10.7474865,"price_display":"10.75","price_state":"stated","total_value":85979.892,"total_display":"85,979.89","total_whole":"85,980","shares_owned_after":640592.0,"shares_owned_after_display":"640,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-21","filed_date":"2024-03-25","scope":"insider","n_lines":2},{"id":2749093,"accession":"0001856414-24-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001856414-24-000004","line_url":"/filing/0001856414-24-000004#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Marriott Tina","owner_display_name":"Marriott Tina","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":14.895,"price_display":"14.90","price_state":"stated","total_value":119160.0,"total_display":"119,160.00","total_whole":"119,160","shares_owned_after":639982.0,"shares_owned_after_display":"639,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-22","filed_date":"2024-02-23","scope":"insider"},{"id":2793521,"accession":"0001209191-24-002391","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-002391","line_url":"/filing/0001209191-24-002391#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":10.3452,"price_display":"10.35","price_state":"stated","total_value":82761.6,"total_display":"82,761.60","total_whole":"82,762","shares_owned_after":414548.0,"shares_owned_after_display":"414,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-29","scope":"insider"},{"id":2585024,"accession":"0001209191-24-000175","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-000175","line_url":"/filing/0001209191-24-000175#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":10.5817,"price_display":"10.58","price_state":"stated","total_value":84653.6,"total_display":"84,653.60","total_whole":"84,654","shares_owned_after":414548.0,"shares_owned_after_display":"414,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-28","filed_date":"2024-01-02","scope":"insider"},{"id":7955303,"accession":"0001209191-23-055846","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-055846","line_url":"/filing/0001209191-23-055846#line-3","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":6.7599,"price_display":"6.76","price_state":"stated","total_value":20279.7,"total_display":"20,279.70","total_whole":"20,280","shares_owned_after":413404.0,"shares_owned_after_display":"413,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8335328,"accession":"0001209191-23-053890","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-053890","line_url":"/filing/0001209191-23-053890#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":5.6283,"price_display":"5.63","price_state":"stated","total_value":16884.9,"total_display":"16,884.90","total_whole":"16,885","shares_owned_after":418782.0,"shares_owned_after_display":"418,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-26","filed_date":"2023-10-30","scope":"insider"},{"id":7999587,"accession":"0001209191-23-051191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-051191","line_url":"/filing/0001209191-23-051191#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.7198,"price_display":"7.72","price_state":"stated","total_value":23159.4,"total_display":"23,159.40","total_whole":"23,159","shares_owned_after":418782.0,"shares_owned_after_display":"418,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-10-02","scope":"insider"},{"id":8296121,"accession":"0001209191-23-047538","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-047538","line_url":"/filing/0001209191-23-047538","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":8.6560982,"price_display":"8.66","price_state":"stated","total_value":25968.2946,"total_display":"25,968.29","total_whole":"25,968","shares_owned_after":418845.0,"shares_owned_after_display":"418,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-28","scope":"insider","n_lines":2},{"id":8078202,"accession":"0001209191-23-043713","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-043713","line_url":"/filing/0001209191-23-043713","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":13.624189225,"price_display":"13.62","price_state":"stated","total_value":108993.5138,"total_display":"108,993.51","total_whole":"108,994","shares_owned_after":424160.0,"shares_owned_after_display":"424,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-27","filed_date":"2023-07-28","scope":"insider","n_lines":2},{"id":7998738,"accession":"0001209191-23-040504","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-040504","line_url":"/filing/0001209191-23-040504#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.49,"price_display":"7.49","price_state":"stated","total_value":22470.0,"total_display":"22,470.00","total_whole":"22,470","shares_owned_after":424160.0,"shares_owned_after_display":"424,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-29","filed_date":"2023-07-03","scope":"insider"},{"id":8294628,"accession":"0001209191-23-033974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-033974","line_url":"/filing/0001209191-23-033974#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":8.6294,"price_display":"8.63","price_state":"stated","total_value":25888.2,"total_display":"25,888.20","total_whole":"25,888","shares_owned_after":424160.0,"shares_owned_after_display":"424,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":7830982,"accession":"0001209191-23-013329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-013329","line_url":"/filing/0001209191-23-013329#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":7.8175,"price_display":"7.82","price_state":"stated","total_value":62540.0,"total_display":"62,540.00","total_whole":"62,540","shares_owned_after":427844.0,"shares_owned_after_display":"427,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-23","filed_date":"2023-02-27","scope":"insider"},{"id":8390827,"accession":"0001209191-23-005316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-005316","line_url":"/filing/0001209191-23-005316#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":8.0684,"price_display":"8.07","price_state":"stated","total_value":64547.2,"total_display":"64,547.20","total_whole":"64,547","shares_owned_after":203654.0,"shares_owned_after_display":"203,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-26","filed_date":"2023-01-27","scope":"insider"},{"id":6927418,"accession":"0001209191-22-063013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-063013","line_url":"/filing/0001209191-22-063013#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":7.6958,"price_display":"7.70","price_state":"stated","total_value":61566.4,"total_display":"61,566.40","total_whole":"61,566","shares_owned_after":203654.0,"shares_owned_after_display":"203,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2022-12-30","scope":"insider"},{"id":6548881,"accession":"0001209191-22-057706","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-057706","line_url":"/filing/0001209191-22-057706#line-3","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":10.9626,"price_display":"10.96","price_state":"stated","total_value":175401.6,"total_display":"175,401.60","total_whole":"175,402","shares_owned_after":203654.0,"shares_owned_after_display":"203,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-17","scope":"insider"},{"id":6431839,"accession":"0001209191-22-054855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-054855","line_url":"/filing/0001209191-22-054855#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":10.7156,"price_display":"10.72","price_state":"stated","total_value":171449.6,"total_display":"171,449.60","total_whole":"171,450","shares_owned_after":205107.0,"shares_owned_after_display":"205,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-27","filed_date":"2022-10-28","scope":"insider"},{"id":6631947,"accession":"0001209191-22-051979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-051979","line_url":"/filing/0001209191-22-051979","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":10.8592936,"price_display":"10.86","price_state":"stated","total_value":173748.6976,"total_display":"173,748.70","total_whole":"173,749","shares_owned_after":205171.0,"shares_owned_after_display":"205,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-29","filed_date":"2022-10-03","scope":"insider","n_lines":2},{"id":6853269,"accession":"0001209191-22-046463","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-046463","line_url":"/filing/0001209191-22-046463#line-3","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":12.6023,"price_display":"12.60","price_state":"stated","total_value":201636.8,"total_display":"201,636.80","total_whole":"201,637","shares_owned_after":295107.0,"shares_owned_after_display":"295,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-17","scope":"insider"},{"id":5385439,"accession":"0001209191-21-070631","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-070631","line_url":"/filing/0001209191-21-070631","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":18.7393608,"price_display":"18.74","price_state":"stated","total_value":46848.402,"total_display":"46,848.40","total_whole":"46,848","shares_owned_after":48840.0,"shares_owned_after_display":"48,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-20","scope":"insider","n_lines":3},{"id":4105792,"accession":"0001209191-21-066261","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066261","line_url":"/filing/0001209191-21-066261","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856414","owner_name":"Larson Tina Marriott","owner_display_name":"Larson Tina Marriott","owner_url":"/insider/0001856414","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":18.9231696,"price_display":"18.92","price_state":"stated","total_value":47307.924,"total_display":"47,307.92","total_whole":"47,308","shares_owned_after":50702.0,"shares_owned_after_display":"50,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-22","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001601830","name":"RECURSION PHARMACEUTICALS, INC.","url":"/issuer/0001601830","role":"Officer (President and COO)","n_filings":27,"first_seen":"2021-11-22","last_seen":"2024-10-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001856414","retrieved_at":"2026-08-24T00:27:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}